A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population
暂无分享,去创建一个
Sylvie Meaume | Jean-Hugues Trouvin | Anne Delahaye | Mathieu Depoisson | Thibault Vallet | L. Lechowski | J. Trouvin | S. Meaume | V. Boudy | S. Gibaud | Yann Orven | Emilie Belissa | Sandra Laribe-Caget | Alain Chevallier | François-Xavier Chedhomme | Patrick Leglise | Matthieu Piccoli | Hugues Michelon | Vanessa Bloch | Anne-Sophie Grancher | Nathalie Bachalat | Imad Boulaich | Fattima Abdallah | Maite Rabus | Jean-Paul Rwabihama | Annie-Claude Ribemont | Celia Lachuer | Ines Perquy | Laurent Lechowski | Caroline Guinot | Stephane Gibaud | Corinne Michel | Abdel Mahiou | Sid-Ahmed Belbachir | Amelie Dufaÿ-Wojcicki | Vincent Boudy | Fabrice Ruiz | A. Chevallier | F. Ruiz | Amélie Dufaÿ-Wojcicki | É. Belissa | C. Guinot | H. Michelon | A. Grancher | F. Chedhomme | J. Rwabihama | C. Lachuer | P. Léglise | A. Ribemont | V. Bloch | Mathieu Depoisson | Thibault Vallet | S. Laribe-Caget | Matthieu Piccoli | Fattima Abdallah | N. Bachalat | Sid-Ahmed Belbachir | Imad Boulaich | A. Delahaye | Abdel Mahiou | Corinne Michel | Yann Orven | Ines Perquy | Maité Rabus
[1] J. Josse,et al. missMDA: A Package for Handling Missing Values in Multivariate Data Analysis , 2016 .
[2] A. Roach,et al. Stability of Esomeprazole Capsule Contents After In Vitro Suspension in Common Soft Foods and Beverages , 2003, Pharmacotherapy.
[3] Anne W. Riley,et al. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[4] N. Lintzeris,et al. Bioavailability of Buprenorphine from Crushed and Whole Buprenorphine (Subutex) Tablets , 2010, European Addiction Research.
[5] W. Haefeli,et al. Swallowing Tablets and Capsules Increases the Risk of Penetration and Aspiration in Patients with Stroke-Induced Dysphagia , 2015, Dysphagia.
[6] O. Ekberg,et al. Quantitative aspects of swallowing in an elderly nondysphagic population , 2004, Dysphagia.
[7] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[8] Joseph F Standing,et al. Poor Formulation Information in Published Pediatric Drug Trials , 2005, Pediatrics.
[9] P. Kozarewicz. Regulatory perspectives on acceptability testing of dosage forms in children. , 2014, International journal of pharmaceutics.
[10] P. Robert,et al. A Unifying Tool for Linear Multivariate Statistical Methods: The RV‐Coefficient , 1976 .
[11] W. Mourier,et al. L’écrasement des médicaments en gériatrie : une pratique « artisanale » avec de fréquentes erreurs qui nécessitait des recommandations , 2012 .
[12] Sébastien Lê,et al. FactoMineR: An R Package for Multivariate Analysis , 2008 .
[13] S. J. Kovacs,et al. The Bioequivalence of Telithromycin Administered Orally as Crushed Tablets Versus Tablets Swallowed Whole , 2005, Journal of clinical pharmacology.
[14] J. Kelly,et al. Administering medication to adult patients with dysphagia. , 2009, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[15] L. Fried,et al. Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[16] J Breitkreutz,et al. Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. , 2012, International journal of pharmaceutics.
[17] A. Aoussat,et al. Standardised evaluation of medicine acceptability in paediatric population: reliability of a model , 2017, The Journal of pharmacy and pharmacology.
[18] B. Dubois,et al. [Mini-Mental State Examination:a useful method for the evaluation of the cognitive status of patients by the clinician. Consensual French version]. , 1999, Presse medicale.
[19] Jérôme Pagès,et al. Testing the significance of the RV coefficient , 2008, Comput. Stat. Data Anal..
[20] Christian Hennig,et al. Cluster-wise assessment of cluster stability , 2007, Comput. Stat. Data Anal..
[21] Catherine Tuleu,et al. Guideline on Pharmaceutical Development of Medicines for Paediatric Use , 2008 .
[22] 崎山美知代. 有効性に関するトピックの動向 ICH E11‐Addendum(R1):Clinical Investigation of Medicinal Products in the Pediatric Population Lisbon2016EWG会議の報告 , 2017 .
[23] L. Janzon,et al. Prevalence of swallowing complaints and clinical findings among 50–79-year-old men and women in an urban population , 2006, Dysphagia.
[24] A. Aoussat,et al. Standardized method to assess medicines’ acceptability: focus on paediatric population , 2016, The Journal of pharmacy and pharmacology.
[25] M. Carrier,et al. Stability and compatibility of tegaserod from crushed tablets mixed in beverages and foods. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[26] J. Remon,et al. Tablet-splitting: a common yet not so innocent practice. , 2011, Journal of advanced nursing.
[27] M. Lawton,et al. Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.
[28] D. V. van Riet-Nales,et al. Patients' appropriateness, acceptability, usability and preferences for pharmaceutical preparations: Results from a literature review on clinical evidence. , 2017, International journal of pharmaceutics.